Insight Molecular Diagnostics Inc. Q4 FY2022 Earnings Call

Insight Molecular Diagnostics Inc. (IMDX)

Earnings Call FY2022 Q4 Call date: 2023-04-03 Concluded

Quarter scorecard

Revenue (derived Q4)

-$3.55M

-198.9% YoY

Gross margin (derived Q4)

-56.4%

Net income (derived Q4)

-$44.98M